Oxford Biomedical Gets $1.2M Grant To Develop Proteomic Toxicity Screening PanelOxford Biomedical Research Inc., a privately held biotechnology company in Rochester Hills, has been awarded a $1,163,600 Phase 2 Small Business Innovation Research Grant by the National Institute of Environmental Health Sciences.

More From CBS Detroit

Hump Day Drinks: 8 Cheery Cocktail RecipesNow that you've made it through half the work week, it's time to celebrate!
Daily J

Watch & Listen